RELB and neoplasm: To assess the impact of RelB on the tumorigenicity of 22Rv1 cells in vivo, we performed subcutaneous injections of 22Rv1-RelB clones or 22Rv1-GFP cells into SCID mice and monitored the rate of tumor growth (Figure 3).